DK518187A - Fremgangsmaade og farmaceutisk praeparat til stimulering af melaminproduktionen i et pattedyr - Google Patents
Fremgangsmaade og farmaceutisk praeparat til stimulering af melaminproduktionen i et pattedyrInfo
- Publication number
- DK518187A DK518187A DK518187A DK518187A DK518187A DK 518187 A DK518187 A DK 518187A DK 518187 A DK518187 A DK 518187A DK 518187 A DK518187 A DK 518187A DK 518187 A DK518187 A DK 518187A
- Authority
- DK
- Denmark
- Prior art keywords
- stimulating
- mammal
- procedure
- pharmaceutical preparation
- melamine production
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/04—Preparations for care of the skin for chemically tanning the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- A61K38/34—Melanocyte stimulating hormone [MSH], e.g. alpha- or beta-melanotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82516286A | 1986-02-03 | 1986-02-03 | |
PCT/US1987/000226 WO1987004623A1 (en) | 1986-02-03 | 1987-01-23 | Method of stimulating melanocytes by topical application of analogs of alpha-msh, and compositions for use in same |
Publications (2)
Publication Number | Publication Date |
---|---|
DK518187D0 DK518187D0 (da) | 1987-10-02 |
DK518187A true DK518187A (da) | 1987-12-02 |
Family
ID=25243274
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK518187A DK518187A (da) | 1986-02-03 | 1987-10-02 | Fremgangsmaade og farmaceutisk praeparat til stimulering af melaminproduktionen i et pattedyr |
Country Status (11)
Country | Link |
---|---|
US (2) | US4918055A (da) |
EP (1) | EP0259440B1 (da) |
KR (1) | KR900005903B1 (da) |
AT (1) | ATE84420T1 (da) |
AU (1) | AU597630B2 (da) |
CA (1) | CA1282324C (da) |
DE (1) | DE3783541T2 (da) |
DK (1) | DK518187A (da) |
IE (1) | IE60883B1 (da) |
NZ (1) | NZ233248A (da) |
WO (1) | WO1987004623A1 (da) |
Families Citing this family (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2711549B2 (ja) * | 1987-06-01 | 1998-02-10 | 圭吉 杉山 | 白髪防止・改善用組成物 |
US5049547A (en) * | 1988-02-11 | 1991-09-17 | University Patents, Inc. | Composition for stimulating integumental melanocytes |
US4874744A (en) * | 1989-03-13 | 1989-10-17 | University Of Cincinnati | Method of using melanocyte stimulating hormone as dermatis treatment |
EP0389950A1 (en) * | 1989-03-23 | 1990-10-03 | Lion Corporation | Melanocyte-stimulating hormone inhibitor and external preparation containing the same |
US5470577A (en) * | 1993-07-07 | 1995-11-28 | Trustees Of Boston University | Stimulation of tanning by DNA fragments or single-stranded DNA |
US5420109A (en) | 1993-11-12 | 1995-05-30 | Houghten Pharmaceuticals, Inc. | Cytokine restraining agents |
US5726156A (en) * | 1995-03-06 | 1998-03-10 | Trega Biosciences, Inc. | Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels |
US5786332A (en) * | 1995-03-06 | 1998-07-28 | Trega Biosciences, Inc. | Cytokine restraining agents and methods of use in pathologies and conditions associated with altered cytokine levels |
FR2733421B1 (fr) * | 1995-04-28 | 1997-06-06 | Oreal | Utilisation de derives de l'hormone stimulatrice des melanocytes de type alpha pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute |
US6001812A (en) * | 1995-04-28 | 1999-12-14 | Societe L'oreal S.A. | Modulating body/cranial hair growth with derivatives of the α-type melanocyte-stimulating hormone |
US5767152A (en) * | 1995-05-04 | 1998-06-16 | Nielsen; Thor Bagger | Composition and methods for stimulating hair growth |
US6696417B1 (en) | 1997-11-21 | 2004-02-24 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Skin and hair darkening composition |
GB9801191D0 (en) * | 1998-01-20 | 1998-03-18 | Unilever Plc | Skin and hair darkening composition |
US6716810B1 (en) * | 1998-12-09 | 2004-04-06 | Eleanor Roosevelt Institute | Composition and method for regulation of body weight and associated conditions |
US6603058B1 (en) | 1998-12-09 | 2003-08-05 | Oklahoma Medical Research Foundation | Non-human animal model for obesity and uses thereof |
DE60029304T2 (de) * | 1999-01-22 | 2007-07-05 | The Schepens Eye Research Institute, Inc., Boston | Aktivierung von regulatorischen t zellen durch ein alpha-melanocyten stimulierendes hormon |
US6800291B1 (en) * | 1999-03-24 | 2004-10-05 | Zengen, Inc. | Uro-genital condition treatment system |
US7402559B2 (en) | 1999-03-24 | 2008-07-22 | Msh Pharma, Incorporated | Composition and method of treatment for urogenital conditions |
ES2295016T3 (es) * | 1999-03-24 | 2008-04-16 | Zengen, Inc. | Secuencias antimicrobianas de aminoacidos derivadas de la hormona estimulante de los alfa-melanocitos. |
AU2001275930B2 (en) * | 2000-07-14 | 2007-05-10 | Eisai Inc. | Alpha-msh related compounds and methods of use |
NZ534450A (en) * | 2002-02-26 | 2008-08-29 | Arizona Board Of Regents Of Be | Method of stimulation of melanin production and induction of skin tanning comprising administering alpha-MSH and exposing skin to UV irradiation |
DE10228837B4 (de) * | 2002-06-27 | 2016-01-07 | Elfriede Rauch | Hautkosmetische Zusammensetzung und Verwendung der Zusammensetzung als Hautbräunungsmittel |
DK1689349T3 (da) | 2003-11-24 | 2013-12-02 | Clinuvel Pharmaceuticals Ltd | Fremgangsmåde til induktion af melanogenese i mennesker med variante MC1R-alleler |
CN101076314A (zh) * | 2004-08-04 | 2007-11-21 | 克里纽沃药物有限公司 | 在对象体内诱导黑素生成的方法 |
EP1812034A4 (en) | 2004-10-08 | 2009-07-29 | Clinuvel Pharmaceuticals Ltd | COMPOSITIONS AND METHODS OF INDUCING MELANOESEES IN ONE PERSON |
US7910101B2 (en) | 2004-10-25 | 2011-03-22 | Centocor, Inc. | Melanocortin receptor binding mimetibodies, compositions, methods and uses |
US7919577B2 (en) | 2004-10-27 | 2011-04-05 | Colorado Seminary | Adrenocorticotropic hormone analogs and related methods |
WO2008015342A2 (fr) * | 2006-08-03 | 2008-02-07 | Societe D'extraction Des Principes Actifs Sa (Vincience) | Utilisation d'un extrait vegetal en tant qu'agent actif pour augmenter la synthese de melanine dans les melanocytes |
WO2008025074A1 (en) | 2006-08-28 | 2008-03-06 | Clinuvel Pharmaceuticals Limited | Method for reducing incidence or rate of development of skin cancers and related conditions |
DK2865422T3 (da) * | 2006-08-31 | 2017-11-20 | Clinuvel Pharmaceuticals Ltd | Alpha-msh-derivater til behandling af fotodermatoser |
RU2009117828A (ru) * | 2006-10-13 | 2010-11-20 | Релайанс Лайф Сайенсиз Пвт. Лтд. (In) | Культивированные меланоциты на биополимерах |
PL2957292T3 (pl) | 2008-03-27 | 2018-04-30 | Clinuvel Pharmaceuticals Limited | Terapia w przypadku bielactwa nabytego |
EP2350031A2 (en) | 2008-08-20 | 2011-08-03 | Ensemble Therapeutics Corporation | Macrocyclic compounds for inhibition of tumor necrosis factor alpha |
US9402877B2 (en) | 2011-11-04 | 2016-08-02 | Xion Pharmaceuticals Corporation | Methods and compositions for oral administration of melanocortin receptor agonist compounds |
US9610461B2 (en) | 2012-03-15 | 2017-04-04 | Galderma Research & Development | Combination of a MC1R receptor agonist and UVB for the treatment and/or prevention of pigmentation disorders |
US9393265B2 (en) | 2013-03-13 | 2016-07-19 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
US9724419B2 (en) | 2013-03-13 | 2017-08-08 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
US9295637B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Compositions and methods for affecting mood states |
US9314422B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
US9393264B2 (en) | 2013-03-13 | 2016-07-19 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
US9314423B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Hair treatment systems and methods using peptides and other compositions |
US9387159B2 (en) | 2013-03-13 | 2016-07-12 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
US9295636B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
US9241899B2 (en) | 2013-03-13 | 2016-01-26 | Transdermal Biotechnology, Inc. | Topical systems and methods for treating sexual dysfunction |
US20140271937A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
US9849160B2 (en) | 2013-03-13 | 2017-12-26 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
US20140271742A1 (en) * | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Skin tanning using peptides and other compositions |
US9687520B2 (en) | 2013-03-13 | 2017-06-27 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
US9320758B2 (en) | 2013-03-13 | 2016-04-26 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
US9314417B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
US9295647B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
US20140271938A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
US9750787B2 (en) | 2013-03-13 | 2017-09-05 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
US9339457B2 (en) | 2013-03-13 | 2016-05-17 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
US20140271731A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
US9314433B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
US9320706B2 (en) | 2013-03-13 | 2016-04-26 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
WO2015063102A1 (en) | 2013-10-28 | 2015-05-07 | Clinuvel Ag | Alpha-msh analogues for use in bullous disease |
WO2015063099A1 (en) | 2013-10-28 | 2015-05-07 | Clinuvel Ag | Alpha-msh analogues for use in the treatment of hailey-hailey disease |
WO2015067503A1 (en) | 2013-11-07 | 2015-05-14 | Clinuvel Ag | Alpha-msh analogues for use in the treatment of psoriasis |
US11202820B2 (en) | 2014-09-25 | 2021-12-21 | Nanyang Technological University | Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages |
US20170304406A1 (en) | 2014-10-28 | 2017-10-26 | Clinuvel Ag | New indication for alpha-msh analogues |
EP3212220A1 (en) | 2014-10-28 | 2017-09-06 | Clinuvel AG | Inflammatory disease |
WO2016195476A1 (en) | 2015-05-29 | 2016-12-08 | Erasmus University Medical Center Rotterdam | Treatment of cardiac arrhythmias |
CN106265134B (zh) * | 2016-03-17 | 2019-02-19 | 哈尔滨源茂达生物技术有限公司 | 一种多肽美白修复精华液及其制备方法 |
US20200246436A1 (en) | 2017-02-01 | 2020-08-06 | Clinuvel Pharmaceuticals Ltd | Alpha-msh analogues used in the treatment of xeroderma pigmentosum |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2158123A1 (de) * | 1970-12-02 | 1972-06-08 | Ciba-Geigy Ag, Basel (Schweiz) | Neue pharmazeutische Präparate |
US4457864A (en) * | 1981-10-23 | 1984-07-03 | University Patents, Inc. | Synthetic analogues of α-melanotropin |
US4485039A (en) * | 1982-06-11 | 1984-11-27 | University Patents, Inc. | Synthetic analogues of α-melanotropin |
DE3623019A1 (de) * | 1986-07-09 | 1988-01-21 | Dieter Prof Dr Dr Aderhold | Melanotropin als therapeutischer wirkstoff |
-
1987
- 1987-01-23 WO PCT/US1987/000226 patent/WO1987004623A1/en active IP Right Grant
- 1987-01-23 DE DE8787901815T patent/DE3783541T2/de not_active Expired - Lifetime
- 1987-01-23 KR KR1019870700899A patent/KR900005903B1/ko not_active IP Right Cessation
- 1987-01-23 EP EP87901815A patent/EP0259440B1/en not_active Expired - Lifetime
- 1987-01-23 AT AT87901815T patent/ATE84420T1/de not_active IP Right Cessation
- 1987-01-23 AU AU70828/87A patent/AU597630B2/en not_active Expired
- 1987-01-29 IE IE23687A patent/IE60883B1/en not_active IP Right Cessation
- 1987-02-03 CA CA000528829A patent/CA1282324C/en not_active Expired - Lifetime
- 1987-02-03 NZ NZ233248A patent/NZ233248A/xx unknown
- 1987-10-02 DK DK518187A patent/DK518187A/da not_active Application Discontinuation
-
1988
- 1988-02-11 US US07/154,823 patent/US4918055A/en not_active Expired - Lifetime
- 1988-07-22 US US07/224,187 patent/US4866038A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0259440B1 (en) | 1993-01-13 |
EP0259440A1 (en) | 1988-03-16 |
AU597630B2 (en) | 1990-06-07 |
US4918055A (en) | 1990-04-17 |
DE3783541T2 (de) | 1993-06-17 |
ATE84420T1 (de) | 1993-01-15 |
IE60883B1 (en) | 1994-08-24 |
US4866038A (en) | 1989-09-12 |
DK518187D0 (da) | 1987-10-02 |
KR900005903B1 (ko) | 1990-08-16 |
DE3783541D1 (de) | 1993-02-25 |
AU7082887A (en) | 1987-08-25 |
WO1987004623A1 (en) | 1987-08-13 |
CA1282324C (en) | 1991-04-02 |
IE870236L (en) | 1987-08-03 |
KR880700670A (ko) | 1988-04-11 |
NZ233248A (en) | 1993-01-27 |
EP0259440A4 (en) | 1989-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK518187D0 (da) | Fremgangsmaade og farmaceutisk praeparat til stimulering af melaminproduktionen i et pattedyr | |
DK634787D0 (da) | Topiske farmaceutiske praeparater til behandling af acne | |
DK285488A (da) | Peptid, praeparat indeholdende peptidet og proevemetode, hvor peptidet anvendes | |
IT1140040B (it) | Derivati di nor-tropano e granatano, loro procedimento di preparazione e loro applicazione in terapia | |
IT1205978B (it) | Derivati di dicloroanilina,composizioni farmaceutiche che li contengono e procedimento per produrli | |
IT1168074B (it) | Derivati amminoalchil-eterociclici, loro procedimento di preparazione e loro applicazione in terapia | |
DK279890A (da) | Liposom-indkapslede vincaalkaloider og anvendelse heraf til fremstilling af et laegemiddel til bekaempelse af tumorer | |
DK132790D0 (da) | Antiinflammatoriske og analgetiske forbindelser, praeparater deraf og metoder til fremstilling og anvendelse deraf | |
DK218985A (da) | Aminocyklopentylaetere, farmaceutiske praeparater indeholdende dem og fremgangsmaade til fremstilling af dem | |
DK355387A (da) | Overtraekspraeparat og fremgangsmaade til anvendelse deraf | |
IT7921922A0 (it) | Procedimento per la determinazione dell'attivita' della colinesterasi e derivati della colina che vengono impiegati nel procedimento. | |
DK315387A (da) | Androst-4-en-3,17-dioner og fremgangsmaade til fremstilling deraf | |
NO173973C (no) | Fremgangsmaate for fremstilling av tabletter som er lett opploeselige og/-eller spaltbare i vann | |
NO870210D0 (no) | Fremgangsmaate og anordning for avskinning. | |
NO895049D0 (no) | Fremgangsmaate for tilvirkning av polyorganosiloksan og ensammensetning som er utherdbar med straaling. | |
DK330687A (da) | Forbindelser og farmaceutiske kompositioner, der er anvendelige som cardiotoniske midler | |
DK424987A (da) | Farmaceutisk praeparat til indgivelse gennem huden og fremgangsmaade til dets fremstilling | |
IT8721958A0 (it) | Derivato di taurina, sua preparazione e composizioni farmaceutiche relative | |
IT8721474A0 (it) | Derivati della taurina. | |
DK180290D0 (da) | Monoxidil-gel og fremgangsmaade til fremstilling deraf | |
DK300381A (da) | Hidtil ukendte 8alfa-oestra-1,3,5 (10)-trienderivater fremganggsmaader til deres fremstilling og farmaceutiske midler | |
DK674587D0 (da) | Anti-forkoelelses-kit, anti-forkoelelsespraeparat og anvendelse deraf | |
SE456221B (sv) | Liggunderlag for bestralningsanleggningar, fremst s k solarier | |
DK74287D0 (da) | Fremgangsmaade til alkoholisk gaering med gaer, hidtil ukendt gaer og anvendelse deraf | |
IT1184965B (it) | Derivato della piparazina,procedimento per la sua preparazione e composizione farmaceutica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |